Kaku, K
It should be a great alternative. Lillys Oral GLP-1, Orforglipron, Delivers Weight Loss of Up to an Average of 27.3 lbs in First of Two Pivotal Phase 3 Trials in Adults With Obesity
Effectiveness: In a study of 2,539 adults with obesity or overweight plus at least one weight-related medical condition (excluding diabetes), the average weight loss at 72 weeks was 15% with 5 mg weekly doses of tirzepatide, 19.5% with 10 mg doses, and almost 21% with 15 mg doses
Abnormalities in this pathway resulted in impaired mitochondrial phospholipid metabolism, disrupted mitochondrial membrane organization, and affected hepatic mitochondrial fatty acid -oxidation and lipid metabolism, potentially contributing to the development of hepatic fibrosis
A large retrospective study showed that high plasma homocysteine in Norwegian women was strongly related to adverse outcomes and complications, including preeclampsia, premature delivery, and very low birth weight, in previous pregnancies (73)